Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:BAD NASDAQ:EQRR NYSEARCA:GERM NASDAQ:TMET On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBADB.A.D. Etf$11.91$11.91$11.11▼$13.72$9.77M0.961,591 shsN/AEQRRProShares Equities For Rising Rates ETF$60.70-0.2%$60.10$50.65▼$62.73$10.32M1.36666 shs7 shsGERMAmplify Treatments, Testing and Advancements ETF$19.16$19.16$15.67▼$20.20$9.67M0.841,891 shsN/ATMETiShares Transition-Enabling Metals ETF$24.26-0.3%$24.83$20.90▼$30.58$9.70M0.13661 shs356 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBADB.A.D. Etf0.00%0.00%0.00%0.00%0.00%EQRRProShares Equities For Rising Rates ETF-0.06%+0.85%+2.55%+3.39%+7.14%GERMAmplify Treatments, Testing and Advancements ETF0.00%0.00%0.00%0.00%+3.11%TMETiShares Transition-Enabling Metals ETF-0.29%+0.12%-5.16%+6.94%-9.14%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBADB.A.D. EtfN/AN/AN/AN/AN/AN/AN/AN/AEQRRProShares Equities For Rising Rates ETFN/AN/AN/AN/AN/AN/AN/AN/AGERMAmplify Treatments, Testing and Advancements ETFN/AN/AN/AN/AN/AN/AN/AN/ATMETiShares Transition-Enabling Metals ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBADB.A.D. Etf 0.00N/AN/AN/AEQRRProShares Equities For Rising Rates ETF 2.71Moderate Buy$60.70N/AGERMAmplify Treatments, Testing and Advancements ETF 0.00N/AN/AN/ATMETiShares Transition-Enabling Metals ETF 2.69Moderate Buy$24.26N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBADB.A.D. EtfN/AN/AN/AN/AN/AN/AEQRRProShares Equities For Rising Rates ETFN/AN/AN/AN/AN/AN/AGERMAmplify Treatments, Testing and Advancements ETFN/AN/AN/AN/AN/AN/ATMETiShares Transition-Enabling Metals ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBADB.A.D. EtfN/AN/A16.67∞N/AN/AN/AN/AN/AEQRRProShares Equities For Rising Rates ETFN/AN/A16.51∞N/AN/AN/AN/AN/AGERMAmplify Treatments, Testing and Advancements ETFN/AN/A7.10∞N/AN/AN/AN/AN/ATMETiShares Transition-Enabling Metals ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBADB.A.D. Etf$0.080.67%N/AN/AN/AEQRRProShares Equities For Rising Rates ETF$1.262.08%N/AN/AN/AGERMAmplify Treatments, Testing and Advancements ETF$0.231.20%N/AN/AN/ATMETiShares Transition-Enabling Metals ETF$6.3326.09%N/AN/AN/ALatest BAD, EQRR, GERM, and TMET DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/24/2025EQRRProShares Equities For Rising Rates ETFQuarterly$0.29902.04%6/25/20256/25/20257/1/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBADB.A.D. EtfN/AEQRRProShares Equities For Rising Rates ETFN/AGERMAmplify Treatments, Testing and Advancements ETFN/ATMETiShares Transition-Enabling Metals ETFN/AInsider OwnershipCompanyInsider OwnershipBADB.A.D. EtfN/AEQRRProShares Equities For Rising Rates ETFN/AGERMAmplify Treatments, Testing and Advancements ETFN/ATMETiShares Transition-Enabling Metals ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBADB.A.D. EtfN/A820,000N/ANot OptionableEQRRProShares Equities For Rising Rates ETFN/A170,000N/ANot OptionableGERMAmplify Treatments, Testing and Advancements ETFN/A500,000N/ANot OptionableTMETiShares Transition-Enabling Metals ETFN/A400,000N/ANot OptionableBAD, EQRR, GERM, and TMET HeadlinesRecent News About These CompaniesShort Interest in iShares Transition-Enabling Metals ETF (NASDAQ:TMET) Decreases By 78.4%August 15 at 2:13 AM | americanbankingnews.comiShares Transition-Enabling Metals ETF (TMET) Dividend HistoryJune 8, 2025 | nasdaq.comiShares Transition-Enabling Metals ETFMay 26, 2025 | fxempire.comFiShares Essential Metals Producers UCITS ETFApril 10, 2025 | barrons.comMaximize Your Dividends With These 3 High-Yield ETFs (TMET)...March 17, 2025 | marketbeat.comMaximize Your Dividends With These 3 High-Yield ETFs (TMET)...March 17, 2025 | marketbeat.comInternational ETFs To Reduce U.S. Market ExposureMarch 7, 2025 | theglobeandmail.comHow the (TMET) price action is used to our AdvantageDecember 11, 2024 | news.stocktradersdaily.comN(TMET) Proactive StrategiesOctober 28, 2024 | news.stocktradersdaily.comNiShares Transition-Enabling Metals ETF (TMET)October 20, 2024 | finance.yahoo.com(TMET) Technical Pivots with Risk ControlsOctober 18, 2024 | news.stocktradersdaily.comNTrading (TMET) With Integrated Risk ControlsOctober 7, 2024 | news.stocktradersdaily.comNCSHI: T-Bill And Options Income ETF, Solid 5.9% Yield And PerformanceSeptember 22, 2024 | seekingalpha.comWhen (TMET) Moves Investors should ListenSeptember 16, 2024 | news.stocktradersdaily.comNIshares Climate Conscious & Transition MSCI USA ETF (USCL)August 31, 2024 | investing.com(TMET) Investment Analysis and AdviceAugust 20, 2024 | news.stocktradersdaily.comNiShares Essential Metals Producers UCITS ETF USD Acc (METL)August 10, 2024 | investing.comHow to Take Advantage of moves in (TMET)August 8, 2024 | news.stocktradersdaily.comNSpot Ethereum ETFs Go Live As Ethereum Readies To Lead Altcoin RallyJuly 23, 2024 | seekingalpha.comBlackRock expands thematic equity suite with manufacturing-focused ETFJuly 19, 2024 | msn.comMedia Sentiment Over TimeBAD, EQRR, GERM, and TMET Company DescriptionsB.A.D. Etf NYSEARCA:BAD$11.91 0.00 (0.00%) As of 11/29/2023The B.A.D. ETF (BAD) is an exchange-traded fund that is based on the EQM BAD index. The fund tracks a modified equal-weighted index of US-listed companies engaged in betting, alcohol, cannabis, and drugs. BAD was launched on Dec 22, 2021 and is managed by The BAD Investment Company.ProShares Equities For Rising Rates ETF NASDAQ:EQRR$60.70 -0.10 (-0.16%) Closing price 08/15/2025Extended Trading$60.75 +0.05 (+0.08%) As of 08/15/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The ProShares Equities for Rising Rates ETF (EQRR) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of 50 US-listed large-cap stocks that are anticipated to perform favorably during periods of rising interest rates. EQRR was launched on Jul 24, 2017 and is managed by ProShares.Amplify Treatments, Testing and Advancements ETF NYSEARCA:GERM$19.16 0.00 (0.00%) As of 08/15/2025The ETFMG Treatments, Testing and Advancements ETF (GERM) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a tier-weighted, narrow index of US-listed, global biotech companies that are engaged in the testing and treatments of infectious diseases. GERM was launched on Jun 17, 2020 and is managed by ETF Managers Group.iShares Transition-Enabling Metals ETF NASDAQ:TMET$24.26 -0.07 (-0.29%) As of 08/15/2025 03:59 PM EasternThe iShares Transition-Enabling Metals ETF (TMET) is an exchange-traded fund that is based on the ICE Clean Energy Transition Metals index. The fund tracks an index that measures the performance of a basket of exchange-traded metals futures contracts. The metals selected are those considered essential to clean energy technologies in supporting the transition to a low-carbon economy. TMET was launched on Sep 26, 2023 and is issued by BlackRock. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Applied Materials' Knee-Jerk Sell-Off Is Your Signal to Buy Buffett’s Mystery Buy Revealed, and It’s a Big Bet on UNH AI Glasses to Replace Smartphones? Meta Is Taking Aim at Apple Deere’s Sell-Off Could Be a Long-Term Buying Chance 3 Restaurant Stocks That Will Outperform in Q3 and Q4 Cisco Systems: The Only AI Stock Income Investors Need to Own Gartner’s RSI Just Sank to 11: That’s a Setup You Can’t Ignore The Real Reason Ford Stock Is Rallying—Can It Keep Going? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access